Free Trial

Arcadia Biosciences (RKDA) Stock Forecast & Price Target

$3.17
+0.17 (+5.67%)
(As of 07/17/2024 ET)

Arcadia Biosciences - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Based on 2 Wall Street analysts who have issued ratings for Arcadia Biosciences in the last 12 months, the stock has a consensus rating of "Strong Buy." Out of the 2 analysts, 1 has given a buy rating, and 1 has given a strong buy rating for RKDA.

Consensus Price Target

$6.00
89.27% Upside
High Forecast$6.00
Average Forecast$6.00
Low Forecast$6.00

According to the 2 analysts' twelve-month price targets for Arcadia Biosciences, the average price target is $6.00. The highest price target for RKDA is $6.00, while the lowest price target for RKDA is $6.00. The average price target represents a forecasted upside of 89.27% from the current price of $3.17.

TypeCurrent Forecast
7/18/23 to 7/17/24
1 Month Ago
6/18/23 to 6/17/24
3 Months Ago
4/19/23 to 4/18/24
1 Year Ago
7/18/22 to 7/18/23
Consensus Rating
Strong Buy
Strong Buy
Buy
Buy
Strong Buy
1 Strong Buy rating(s)
1 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
1 Buy rating(s)
1 Buy rating(s)
1 Buy rating(s)
1 Buy rating(s)
Hold
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$6.00$6.00$10.00$17.50
Forecasted Upside89.27% Upside115.83% Upside378.47% Upside168.13% Upside
Get Arcadia Biosciences Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for RKDA and its competitors with MarketBeat's FREE daily newsletter.

RKDA Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

RKDA Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Arcadia Biosciences Stock vs. The Competition

TypeArcadia BiosciencesBasic Materials CompaniesS&P 500
Consensus Rating Score
3.50
2.63
2.51
Consensus RatingStrong BuyModerate BuyModerate Buy
Predicted Upside89.87% Upside366.83% Upside7.69% Upside
News Sentiment RatingPositive News
Neutral News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
5/23/2024HC Wainwright
3 of 5 stars
 Lower TargetBuy ➝ Buy$10.00 ➝ $6.00+115.83%
5/14/2024Lake Street Capital
3 of 5 stars
B. Klieve
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 10:39 PM ET.

RKDA Forecast - Frequently Asked Questions

What is Arcadia Biosciences' forecast for 2024?

According to the research reports of 2 Wall Street equities research analysts, the average twelve-month stock price forecast for Arcadia Biosciences is $6.00, with a high forecast of $6.00 and a low forecast of $6.00.

Should I buy or sell Arcadia Biosciences stock right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Arcadia Biosciences in the last twelve months. There is currently 1 buy rating and 1 strong buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "strong buy" RKDA shares.

Does Arcadia Biosciences's stock price have much upside?

According to analysts, Arcadia Biosciences's stock has a predicted upside of 115.83% based on their 12-month stock forecasts.

Has Arcadia Biosciences been upgraded by Wall Street analysts recently?

Over the previous 90 days, Arcadia Biosciences's stock had 1 upgrade by analysts.

What analysts cover Arcadia Biosciences?

Arcadia Biosciences has been rated by research analysts at HC Wainwright, and Lake Street Capital in the past 90 days.

Do Wall Street analysts like Arcadia Biosciences more than its competitors?

Analysts like Arcadia Biosciences more than other "basic materials" companies. The consensus rating for Arcadia Biosciences is Strong Buy while the average consensus rating for "basic materials" companies is Moderate Buy. Learn more on how RKDA compares to other companies.


This page (NASDAQ:RKDA) was last updated on 7/17/2024 by MarketBeat.com Staff

From Our Partners